Tokyo Women’s Medical University has stripped a researcher of her PhD, following the retraction of a paper — for data duplication — that was based on her thesis.
The August 30th announcement notes that a degree was revoked on July 20. The announcement does not name the researcher, but refers to degree number 2881, which corresponds to Rika Nakayama’s PhD. The university describes carelessness and errors, but not misconduct.
Five journals published by a prominent cancer research society have retracted a total of 10 papers — most of them by a former researcher at the MD Anderson Cancer Center in Houston.
Nine of the 10 retractions share that researcher, Bharat Aggarwal, as an author. Aggarwal — who more than five years ago threatened to sue us for reporting on an investigation into his work — is now up to 28 retractions, and has left his post at MD Anderson. The AACR is also appending an editor’s note to eight of his other papers — but it has not explained the reason for what it acknowledges is a lag in moving on these articles.
According to one notice for “In-silico Analysis of LncRNA-mRNA Target Prediction” in: D. Reddy Edla et al. (eds.), Advances in Machine Learning and Data Science, Advances in Intelligent Systems and Computing 705, the chapter was retracted for plagiarism.
A liver physiologist at the University of Connecticut with millions of dollars in Federal U.S. funding included false data in half a dozen grant applications, according to the U.S. Office of Research Integrity.
A researcher who was found guilty of committing misconduct while using three federal grants has published new findings that cite those grants.
In 2012, the U.S. Office of Research Integrity determined that Michael Miller, a former department chair at the State University of New York (SUNY) Upstate Medical University in Syracuse, had committed misconduct by falsifying and/or fabricating data. The affected research was funded by three grants issued by the National Institute of Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH).
Gilbert Welch, one of the most prominent health care policy researchers in the U.S., has been found guilty of research misconduct following an investigation by Dartmouth College, his employer.
Retraction Watch readers may have followed our coverage of the case of Christian Kreipke, a former Wayne State researcher who was recently barred from U.S. Federal funding for five years. That punishment followed years of allegations and court cases, along with half a dozen retractions. The case has been complicated, to say the least, and led to a 126-page decision by a judge last month. Here, Boston-based attorney Richard Goldstein, who represented the scientist in Bois v. HHS, the first case to overturn a funding ban by the U.S. Office of Research Integrity (ORI), tries to explain what it could all mean.
A professor specializing in the health of children and pregnant women has left her post at the University of Glasgow, and issued three retractions in recent months.
All three notices — issued by PLOS ONE — mention an investigation at the university, which found signs of data manipulation and falsification. Fiona Lyall, the last author on all three papers, is also the only author in common to all three papers; she did not respond to the journal’s inquiries.
According to the University of Glasgow, the affiliation listed for Lyall, she is no longer based at the university. When we asked about the circumstances of her departure, the spokesperson told us the university has a “commitment to confidentiality,” but noted:
Sometimes, corrections are so extensive, they can only be called one thing: Mega-corrections.
Recently, the Proceedings of the National Academy of Sciences (PNAS) issued a four-page correction notice to a paper about a compound that appeared to reduce the chances a cancer will recur. The notice describes figure duplication, problems with error bars and figure legends — as well as the loss of statistical significance for some data.
According to the authors’ statement in the notice: